Aptorum Group (APM) Competitors $0.94 +0.03 (+2.75%) Closing price 07/1/2025 03:57 PM EasternExtended Trading$0.94 0.00 (0.00%) As of 07/1/2025 04:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock APM vs. PHGE, PASG, CVKD, SLGL, RLMD, GBIO, BCTX, CALC, NAII, and LGVNShould you be buying Aptorum Group stock or one of its competitors? The main competitors of Aptorum Group include BiomX (PHGE), Passage Bio (PASG), Cadrenal Therapeutics (CVKD), Sol-Gel Technologies (SLGL), Relmada Therapeutics (RLMD), Generation Bio (GBIO), Briacell Therap (BCTX), CalciMedica (CALC), Natural Alternatives International (NAII), and Longeveron (LGVN). These companies are all part of the "pharmaceutical products" industry. Aptorum Group vs. Its Competitors BiomX Passage Bio Cadrenal Therapeutics Sol-Gel Technologies Relmada Therapeutics Generation Bio Briacell Therap CalciMedica Natural Alternatives International Longeveron Aptorum Group (NASDAQ:APM) and BiomX (NYSEMKT:PHGE) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, risk, media sentiment, institutional ownership, earnings, valuation and profitability. Do analysts recommend APM or PHGE? BiomX has a consensus target price of $21.00, suggesting a potential upside of 4,577.06%. Given BiomX's stronger consensus rating and higher probable upside, analysts clearly believe BiomX is more favorable than Aptorum Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aptorum Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00BiomX 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more volatility & risk, APM or PHGE? Aptorum Group has a beta of -0.17, meaning that its stock price is 117% less volatile than the S&P 500. Comparatively, BiomX has a beta of 1.43, meaning that its stock price is 43% more volatile than the S&P 500. Does the media refer more to APM or PHGE? In the previous week, Aptorum Group had 3 more articles in the media than BiomX. MarketBeat recorded 3 mentions for Aptorum Group and 0 mentions for BiomX. Aptorum Group's average media sentiment score of 0.47 beat BiomX's score of 0.00 indicating that Aptorum Group is being referred to more favorably in the media. Company Overall Sentiment Aptorum Group Neutral BiomX Neutral Which has preferable earnings and valuation, APM or PHGE? Aptorum Group has higher revenue and earnings than BiomX. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAptorum Group$430K11.63-$4.27MN/AN/ABiomXN/AN/A-$28.32M-$0.85-0.53 Is APM or PHGE more profitable? Aptorum Group's return on equity of 0.00% beat BiomX's return on equity.Company Net Margins Return on Equity Return on Assets Aptorum GroupN/A N/A N/A BiomX N/A -127.82%-56.50% Do insiders & institutionals hold more shares of APM or PHGE? 3.8% of Aptorum Group shares are held by institutional investors. Comparatively, 40.6% of BiomX shares are held by institutional investors. 64.0% of Aptorum Group shares are held by insiders. Comparatively, 1.2% of BiomX shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. SummaryAptorum Group beats BiomX on 7 of the 12 factors compared between the two stocks. Get Aptorum Group News Delivered to You Automatically Sign up to receive the latest news and ratings for APM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding APM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart APM vs. The Competition Export to ExcelMetricAptorum GroupMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.87M$2.43B$5.48B$8.94BDividend YieldN/A1.79%5.38%4.12%P/E RatioN/A8.7826.2219.74Price / Sales11.63636.32405.42109.12Price / CashN/A154.3736.4957.06Price / Book0.434.467.945.37Net Income-$4.27M$31.16M$3.15B$248.34M7 Day Performance-6.57%0.38%0.77%1.67%1 Month Performance-6.50%8.14%3.47%4.56%1 Year Performance-76.74%3.02%34.86%18.42% Aptorum Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)APMAptorum Group0.7722 of 5 stars$0.94+2.7%N/A-77.0%$4.87M$430K0.0030News CoverageGap UpPHGEBiomXN/A$0.45-38.7%$21.00+4,535.8%-86.8%$12.54MN/A-0.60120PASGPassage Bio2.875 of 5 stars$0.40+20.9%$7.50+1,773.6%-57.0%$20.58MN/A-0.39130News CoverageGap UpCVKDCadrenal Therapeutics3.6478 of 5 stars$12.05+15.4%$32.00+165.6%N/A$20.53MN/A-1.304Positive NewsGap UpHigh Trading VolumeSLGLSol-Gel Technologies2.6724 of 5 stars$7.40+1.1%$40.00+440.5%-14.0%$20.39M$11.54M-1.5750RLMDRelmada Therapeutics4.7849 of 5 stars$0.60-1.6%$5.00+732.9%-79.9%$20.25MN/A-0.2410Gap UpGBIOGeneration Bio3.4415 of 5 stars$0.32+6.6%$7.33+2,191.0%-87.5%$20.14M$19.89M-0.30150Gap UpHigh Trading VolumeBCTXBriacell Therap3.0532 of 5 stars$2.94-0.7%$32.00+988.4%-82.5%$20.06MN/A-0.358CALCCalciMedica3.2073 of 5 stars$1.60+11.9%$18.00+1,025.0%-63.3%$19.98MN/A-1.0330Gap UpNAIINatural Alternatives International1.1126 of 5 stars$3.28+1.9%N/A-42.8%$19.90M$113.80M-2.36290News CoveragePositive NewsLGVNLongeveron3.7494 of 5 stars$1.30-1.5%$8.67+566.7%-18.5%$19.70M$2.39M-0.2120 Related Companies and Tools Related Companies PHGE Competitors PASG Competitors CVKD Competitors SLGL Competitors RLMD Competitors GBIO Competitors BCTX Competitors CALC Competitors NAII Competitors LGVN Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:APM) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThe #1 AI Energy StockNearly $600 billion is projected to be spent on AI data centers this year. That's because the ones being bu...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aptorum Group Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Aptorum Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
